Post-AKI Monitoring Gaps Risk Long-Term CKD: Thai Dang, MD

Patients who survive an acute kidney injury (AKI) episode face significant long-term risks that extend far beyond the initial hospitalization, including elevated rates of cardiovascular death and myocardial infarction, making structured post-AKI follow-up essential, Thai Dang, MD, a hospitalist at Kelsey-Seybold, said in an interview with The American Journal of Managed Care^® at a recent Institute for Value-Based Care population health event cohosted with Optum.

Post-AKI Monitoring: How Closely and How Soon

Dang emphasized that the intensity of post-discharge monitoring should be calibrated to the severity of the AKI episode. For patients who experienced a mild AKI, repeating kidney function labs within 1 to 2 weeks is generally appropriate to confirm normalization. Patients with more severe AKI, such as those whose creatinine rises by 1 point or more, require closer surveillance, with renal function checks recommended within 2 to 3 days of discharge.

Dang noted that this tiered approach is rooted in expert consensus rather than formal guideline language, as the “guidelines aren't that detailed yet.”

That distinction carries practical weight for hospitalists and primary care physicians navigating post-AKI care without a clear roadmap, Dang suggested. The gap between expert opinion and codified guidance reflects how recently the field has recognized AKI as a gateway to chronic kidney disease (CKD) and other long-term complications, not simply an acute event to be resolved and forgotten.

Medication Management and the Limits of General Awareness

Dang stressed that medication adjustment is among the most consequential decisions providers face during an AKI episode. He described holding angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and diuretics as a standard early step because continuing those agents during active injury can worsen outcomes rather than improve them. Collaboration with nephrology, he added, is essential to developing institution-specific protocols for which medications to hold and when to restart them.

The challenge extends to over-the-counter medications that patients often take without consulting a physician. Nonsteroidal anti-inflammatory drugs and certain bowel regimens, including some enemas, can worsen AKI, yet many patients and even primary care physicians are unaware of that risk.

"I think the general population, and even most primary care physicians, don't recognize that," Dang said. "I think it's important that we continue to improve the messaging so that they would be aware whenever they encounter somebody with acute kidney injury."

Dang called for broader education efforts targeting both clinicians and patients to close that awareness gap and reduce the risk of preventable progression to permanent CKD.